TY  - GEN
AU  - Mahler,Donald A
AU  - Waterman,Laurie A
AU  - Ward,Joseph
AU  - Gifford,Alex H
TI  - Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate
SN  - 1941-2703
PY  - 2015///0409
KW  - Administration, Inhalation
KW  - Adrenergic beta-2 Receptor Agonists
KW  - administration & dosage
KW  - Aerosols
KW  - Aged
KW  - Aged, 80 and over
KW  - Albuterol
KW  - Bronchodilator Agents
KW  - Cross-Over Studies
KW  - Drug Delivery Systems
KW  - instrumentation
KW  - Ethanolamines
KW  - Female
KW  - Forced Expiratory Volume
KW  - Formoterol Fumarate
KW  - Humans
KW  - Inhalation
KW  - drug effects
KW  - Lung
KW  - Male
KW  - Middle Aged
KW  - Nebulizers and Vaporizers
KW  - New Hampshire
KW  - Patient Preference
KW  - Powders
KW  - Prospective Studies
KW  - Pulmonary Disease, Chronic Obstructive
KW  - diagnosis
KW  - Salmeterol Xinafoate
KW  - Single-Blind Method
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vital Capacity
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1089/jamp.2013.1038
ER  -